Showing 101-120 of 511 for: Cochrane Systematic Reviews > Infectious disease 
- Artesunate versus quinine for treating severe malaria
Cochrane Systematic Reviews, 13-Jun-2012
Severe malaria results in over a million deaths every year, most of them in children aged under five years and living in sub-Saharan Africa. This review examines whether treatment with artesunate, instead of the standard treatment quinine, would result in
- Artificial and bioartificial support systems for liver failure
Cochrane Systematic Reviews, 26-Jan-2004
Artificial and bioartificial liver support systems may 'bridge' patients with acute or acute-on-chronic liver failure to liver transplantation or recovery.
- Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
Cochrane Systematic Reviews, 18-Jan-2021
The World Health Organization (WHO) in 2015 stated atovaquone-proguanil can be used in travellers, and is an option in malaria-endemic areas in combination with artesunate, as an alternative treatment where first-line artemisinin-based combination therapy
- Autologous platelet-rich plasma for treating chronic wounds
Cochrane Systematic Reviews, 24-May-2016
Autologous platelet-rich plasma (PRP) is a treatment that contains fibrin and high concentrations of growth factors with the potential to improve the healing of chronic wounds. This is the first update of a review first published in 2012.
- Azathioprine for primary biliary cirrhosis
Cochrane Systematic Reviews, 18-Jul-2007
Azathioprine is used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been conflicting.
- Azithromycin for acute lower respiratory tract infections
Cochrane Systematic Reviews, 8-Mar-2015
Acute lower respiratory tract infections (LRTI) range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia. Approximately five million people die from acute respiratory tract infections annually. Among these, pneumonia represen
- Azithromycin for treating uncomplicated malaria
Cochrane Systematic Reviews, 11-Apr-2011
To prevent the development of drug resistance, the World Health Organization (WHO) recommends treating malaria with combination therapy. Azithromycin, an antibiotic with antimalarial properties, may be a useful additional option for antimalarial therapy.
- Azithromycin versus penicillin G benzathine for early syphilis
Cochrane Systematic Reviews, 17-May-2012
Syphilis is a complex systemic disease caused by a spirochete, Treponema pallidum. The World Health Organization estimates that at least 12 million people worldwide are currently infected with syphilis. In this review we compared two current standards of
- Azoles for allergic bronchopulmonary aspergillosis associated with asthma
Cochrane Systematic Reviews, 19-Jul-2004
Allergic bronchopulmonary aspergillosis is hypersensitivity to the fungus Aspergillus fumigatus that complicates patients with asthma and cystic fibrosis. The mainstay of treatment for allergic bronchopulmonary aspergillosis remains oral corticosteroids,
- Behavioral interventions for improving contraceptive use among women living with HIV
Cochrane Systematic Reviews, 9-Aug-2016
Contraception services can help meet the family planning goals of women living with HIV as well as prevent mother-to-child transmission. Due to antiretroviral therapy, survival has improved for people living with HIV, and more HIV-positive women may desir
- Behavioral interventions to promote condom use among women living with HIV
Cochrane Systematic Reviews, 18-Jan-2012
High rates of HIV infection among women of reproductive age have dramatic consequences for personal and public health. Prophylaxis during sexual intercourse in the form of condoms has been the most effective way to prevent both STI and HIV transmission am
- Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men
Cochrane Systematic Reviews, 14-May-2008
Men who have sex with men (MSM) remain at great risk for HIV infection. Program planners and policy makers need descriptions of interventions and quantitative estimates of intervention effects to make informed decisions concerning prevention funding and r
- Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high-income countries
Cochrane Systematic Reviews, 4-Nov-2011
Interventions to change behaviour among sex workers and their clients have been identified as a strategy to reduce HIV transmission. However, there has been no systematic review that has examined and summarized their effects.
- Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in low- and middle-income countries
Cochrane Systematic Reviews, 17-Jan-2012
Various interventions have been adopted to reduce HIV transmission among sex workers and their clients but the effectiveness of these strategies has yet to be investigated using meta-analytic techniques.
- Benzodiazepines and related drugs for insomnia in palliative care
Cochrane Systematic Reviews, 22-Nov-2013
Insomnia, a subjective complaint of poor sleep and associated impairment in daytime function, is a common problem. Currently, benzodiazepines are the most used pharmacological treatment for this complaint. They are considered helpful for occasional short-
- Benzodiazepines for alcohol withdrawal
Cochrane Systematic Reviews, 17-Mar-2010
Alcohol abuse and dependence represents a serious health problem worldwide with social, interpersonal and legal interpolations. Benzodiazepines have been widely used for the treatment of alcohol withdrawal symptoms. Moreover it is unknown whether differen
- Benzodiazepines for antipsychotic‐induced tardive dyskinesia
Cochrane Systematic Reviews, 20-Jan-2018
Tardive dyskinesia (TD) is a disfiguring movement disorder, often of the orofacial region, frequently caused by using antipsychotic drugs. A wide range of strategies have been used to help manage TD, and for those who are unable to have their antipsychoti
- Benzodiazepines for neuroleptic‐induced acute akathisia
Cochrane Systematic Reviews, 25-Oct-1999
Neuroleptic-induced akathisia is one of the most common and distressing early-onset adverse effects of antipsychotic drugs, being associated with poor compliance with treatment, and thus, ultimately, to an increase risk of relapse. This review assesses th
- Benzodiazepines for psychosis‐induced aggression or agitation
Cochrane Systematic Reviews, 8-Dec-2017
Acute psychotic illness, especially when associated with agitated or violent behaviour, can require urgent pharmacological tranquillisation or sedation. In several countries, clinicians often use benzodiazepines (either alone or in combination with antips
- Benzodiazepines for schizophrenia
Cochrane Systematic Reviews, 14-Nov-2012
Because of the high number of people with schizophrenia not responding adequately to monotherapy with antipsychotic agents, the evidence regarding the efficacy and safety of additional medication was examined in a number of clinical trials. One approach t
